# Task C20: Therapeutic Studies for Lyme Disease

> **NIH NIH N01** · ALBANY MOLECULAR RESEARCH, INC. · 2022 · $443,000

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins, including chemistry and GMP manufacturing.

## Key facts

- **NIH application ID:** 10710598
- **Project number:** 272201800008I-0-759302200003-1
- **Recipient organization:** ALBANY MOLECULAR RESEARCH, INC.
- **Principal Investigator:** JOSÉ-LUIS BARREDO,
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $443,000
- **Award type:** —
- **Project period:** 2022-09-14 → 2022-12-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10710598

## Citation

> US National Institutes of Health, RePORTER application 10710598, Task C20: Therapeutic Studies for Lyme Disease (272201800008I-0-759302200003-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10710598. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*